A Study of VRT106 for Injection in Patients With Recurrent/Progressive Glioblastoma
Clinical trial NCT07093814 · RECRUITING
Trial details
- NCT number
- NCT07093814
- Sponsor
- Guangzhou Virotech Pharmaceutical Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-02
- Primary completion
- 2028-12-31
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.